Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Body composition optimization" is not a molecular target, receptor, enzyme, transporter, or any specific biological molecule. Instead, it refers to the process or goal of improving the ratio of fat to non-fat components (such as muscle and bone) in the human body. This concept is widely used in health and fitness contexts to describe interventions aimed at reducing excess body fat while preserving or increasing lean muscle and bone mass. Methods for assessing body composition include dual-energy X-ray absorptiometry (DEXA), bioelectrical impedance analysis (BIA), skinfold measurements, and hydrostatic weighing[1][2][3][4]. Optimizing body composition can reduce risks associated with obesity—such as cardiovascular disease and diabetes—and improve overall health outcomes. However, because "body composition optimization" does not refer to a discrete molecular entity but rather an "outcome measure" or clinical goal influenced by many physiological pathways (including hormonal regulation by thyroid hormones, growth hormone, steroid hormones), it should not be classified as a therapeutic target in drug discovery terms[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Body composition optimization.